{
  "zip": "07024",
  "sector": "Healthcare",
  "fullTimeEmployees": 7,
  "longBusinessSummary": "Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of various therapeutic agents for the treatment of immunologic and inflammatory diseases. The company's lead product candidate is bertilimumab, a human antibody, which is in Phase II clinical trials that targets eotaxin-1 for the treatment of bullous pemphigoid and ulcerative colitis. It is also developing NanoCyclo, a nano-encapsulated formulation of cyclosporine-A, which is in late stage preclinical development for atopic dermatitis and psoriasis. In addition, the company's pain products include AmiKet and AmiKet Nano, a topical analgesic cream containing amitriptyline and ketamine for the treatment of postherpetic neuralgia and diabetic peripheral neuropathy. Further, its oncology portfolio comprises Ceplene, for the maintenance of remission in patients with acute myeloid leukemia in combination with interleukin-2; Azixa and crolibulin that are clinical-stage vascular disrupting agents; NanomAbs, a nanotechnology combination platform; and bispecific antibody platform. Immune Pharmaceuticals, Inc. was founded in 2010 and is based in Fort Lee, New Jersey. On April 2, 2020, the voluntary petition of Immune Pharmaceuticals, Inc. along with its affiliates, for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on February 17, 2020.",
  "city": "Fort Lee",
  "phone": "201-464-2677",
  "state": "NJ",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.immunepharma.com",
  "maxAge": 1,
  "address1": "1 Bridge Plaza North",
  "industry": "Biotechnology",
  "address2": "Suite 270",
  "previousClose": 0.009,
  "regularMarketOpen": 0.01,
  "twoHundredDayAverage": 0.004139718,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.01,
  "navPrice": null,
  "averageDailyVolume10Day": 584219,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.009,
  "fiftyDayAverage": 0.007292647,
  "trailingAnnualDividendRate": null,
  "open": 0.01,
  "averageVolume10days": 584219,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.705357,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.008,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 173511,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 1564546,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 410910,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.008,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 173511,
  "fiftyTwoWeekHigh": 0.0165,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.001,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.01,
  "exchange": "PNK",
  "shortName": "IMMUNE PHARMACEUTICALS INC",
  "longName": "Immune Pharmaceuticals, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "IMNPQ",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_112205409",
  "uuid": "c7cb55bc-ce50-3601-9468-954df0775e7a",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -0.632,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 172878000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.019,
  "sharesShort": 1079200,
  "sharesPercentSharesOut": 0.03,
  "fundFamily": null,
  "lastFiscalYearEnd": 1514678400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -34386000,
  "trailingEps": -1.147,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 0.47631583,
  "heldPercentInsiders": 0.0652,
  "nextFiscalYearEnd": 1577750400,
  "mostRecentQuarter": 1538265600,
  "shortRatio": 1.32,
  "sharesShortPreviousMonthDate": 1529020800,
  "floatShares": 46257382,
  "enterpriseValue": 8699820,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1492041600,
  "lastSplitFactor": "1:20",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1531440000,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0342,
  "sharesShortPriorMonth": 865075,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.01,
  "logo_url": "https://logo.clearbit.com/immunepharma.com"
}